We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals trimethylamine N-oxide is a biomarker for risk stratification in chronic kidney disease, indicating its potential clinical utility.
Clinical Trails.gov identifier, ChiCTR2400089774 (retrospectively registered in 14/09/2024).
No takes yet. Share an insight, caveat, or question.
Lei et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: